Testing effectiveness (Phase 2)Study completedNCT02873975
What this trial is testing
LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
Who this might be right for
Advanced Cancers
Dana-Farber Cancer Institute 27